Toxicities and outcomes for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, pharmacokinetically-targeted (PR) busulfan (Bu), cyclophosphamide (TBC) conditioning Meeting Abstract


Authors: Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
Abstract Title: Toxicities and outcomes for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, pharmacokinetically-targeted (PR) busulfan (Bu), cyclophosphamide (TBC) conditioning
Meeting Title: 2016 BMT Tandem Meetings
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 22
Issue: 3 Suppl. 1
Meeting Dates: 2016 Feb 18-22
Meeting Location: Honolulu, HI
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2016-03-01
Start Page: S132
End Page: S133
Language: English
ACCESSION: WOS:000370910300160
PROVIDER: wos
DOI: 10.1016/j.bbmt.2015.11.465
Notes: Meeting Abstract: 155 -- Source: Wos
Altmetric Score
MSK Authors
  1. Meier Hsu
    104 Hsu
  2. Craig Moskowitz
    375 Moskowitz
  3. Sergio Andres Giralt
    537 Giralt
  4. Antonio Marcilio Padula Omuro
    177 Omuro
  5. Craig Steven Sauter
    167 Sauter
  6. Matthew J Matasar
    122 Matasar
  7. Valkal Bhatt
    33 Bhatt
  8. Parastoo Bahrami Dahi
    85 Dahi
  9. Michael Scordo
    39 Scordo